4967:TSEKobayashi Pharmaceutical Co., Ltd. Analysis
Data as of 2026-08-31 - not real-time
¥5,690.00
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
Kobayashi Pharmaceutical Co., Ltd. is priced at ¥5,690.00, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has gained 3.1%. Momentum indicators put RSI at 57.5 (neutral) with MACD reading bullish. Watch ¥5,446.00 as support and ¥5,739.00 as the nearer resistance level.
Valuation screens as overvalued, on a P/E of 263.2 with no clean sector comparison available. Consensus targets land 3.4% below where the shares trade now. The 1.86% dividend yield looks stretched against payout coverage.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 23.1%, a beta of -0.11 and a maximum drawdown of 13.6%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.
Valuation screens as overvalued, on a P/E of 263.2 with no clean sector comparison available. Consensus targets land 3.4% below where the shares trade now. The 1.86% dividend yield looks stretched against payout coverage.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 23.1%, a beta of -0.11 and a maximum drawdown of 13.6%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.
Top Market Events
MarketWatch3monKobayashi Pharmaceutical 1Q Net Y1.Kobayashi Pharmaceutical Co shares in Japan are trading broadly stable in the wake of the company’sInvesting5monKobayashi Pharmaceutical Co LtdThe chart above depicts the distribution of Revenue for companies operating...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading above the 200-day average of 5572.74
- MACD momentum is positive
- RSI at 57.5 is in neutral territory
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Dividend yield of 1.86% looks stretched against payout coverage
- Trading above the 200-day average of 5572.74
- MACD momentum is positive
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Dividend yield of 1.86% looks stretched against payout coverage
- Negative free cash flow
- P/E ratio of 263.2
Key Metrics & Analysis
Financial Health
Revenue Growth1.80%
Profit Margin0.97%
P/E Ratio263.2
ROE0.78%
ROA2.53%
Debt/Equity0.34
P/B Ratio2.0
Op. Cash Flow¥11.8B
Free Cash Flow¥-12648875008
Technical Analysis
TrendNeutral
RSI57.5
Support¥5,446.00
Resistance¥5,739.00
MA 20¥5,592.50
MA 50¥5,563.48
MA 200¥5,572.75
MACDBullish
VolumeDecreasing
Fear & Greed Index94.18
Valuation
Fair Value¥2,308.65
Target Price¥5,496.25
Upside/Downside-3.41%
GradeOvervalued
TypeBlend
Dividend Yield1.86%
Risk Assessment
Beta-0.11
Volatility23.07%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.